Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.
D000328:Adult; D000368:Aged; D000658:Amoxicillin / Q000494:pharmacology* / Q000652:urine; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000652:urine; D019818:Clavulanic Acid; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology; D005260:Female; D006801:Humans; D008875:Middle Aged; D011513:Proteus mirabilis / Q000187:drug effects* / Q000201:enzymology; D014552:Urinary Tract Infections / Q000378:metabolism / Q000382:microbiology*; D001618:beta-Lactamases / Q000378:metabolism; D047090:beta-Lactams / Q000494:pharmacology / Q000652:urine
D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D019818:Clavulanic Acid; D000658:Amoxicillin; D001618:beta-Lactamases